tradingkey.logo

Kamada Ltd

KMDA
View Detailed Chart

7.220USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
415.19MMarket Cap
25.85P/E TTM

Kamada Ltd

7.220

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.30%

5 Days

-6.48%

1 Month

-8.38%

6 Months

+6.80%

Year to Date

+18.56%

1 Year

+34.20%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts
BUY
Current Rating
14.750
Target Price
104.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

173
Total
5
Median
8
Average
Company name
Ratings
Analysts
Kamada Ltd
KMDA
3
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
34
Vertex Pharmaceuticals Inc
VRTX
34
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(2)
Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.145
Neutral
RSI(14)
40.070
Neutral
STOCH(KDJ)(9,3,3)
22.023
Sell
ATR(14)
0.215
Low Volatility
CCI(14)
-187.506
Sell
Williams %R
75.824
Sell
TRIX(12,20)
0.049
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
7.464
Sell
MA10
7.617
Sell
MA20
7.649
Sell
MA50
7.358
Sell
MA100
7.003
Buy
MA200
6.715
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Ticker SymbolKMDA
CompanyKamada Ltd
CEOMr. Amir London
Websitehttps://www.kamada.com/
KeyAI